RATIO-CITALOPRAM 20 MG
CITALOPRAM (CITALOPRAM HYDROBROMIDE) : 20 MG · DIN 02252112 · TEVA CANADA LIMITED
Health Canada status: CANCELLED POST MARKET
What is RATIO-CITALOPRAM?
RATIO-CITALOPRAM 20 MG contains CITALOPRAM (CITALOPRAM HYDROBROMIDE) : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 02252112, held by TEVA CANADA LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 21-Dec-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02252112 |
|---|---|
| Brand name | RATIO-CITALOPRAM |
| Generic / active ingredient | CITALOPRAM (CITALOPRAM HYDROBROMIDE) : 20 MG |
| Manufacturer | TEVA CANADA LIMITED |
| Strength | 20 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N06AB04 CITALOPRAM |
| AHFS class | 28:16.04.20 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 21-Dec-2012 |
| Original market date | 2004-04-26 00:00:00 |
Is CITALOPRAM in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by JAMP PHARMA CORPORATION, last seen 03 Aug 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code N06AB04 CITALOPRAM. 55 of 149 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AG-CITALOPRAM | 10 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02374617 |
| AG-CITALOPRAM | 20 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02339390 |
| AG-CITALOPRAM | 40 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02339404 |
| AG-CITALOPRAM TABLETS | 10 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02513676 |
| AG-CITALOPRAM TABLETS | 20 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02513684 |
| AG-CITALOPRAM TABLETS | 30 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02543060 |
| AG-CITALOPRAM TABLETS | 40 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02513692 |
| APO-CITALOPRAM | 20 MG | TABLET | APOTEX INC | MARKETED | DIN 02246056 |
| APO-CITALOPRAM | 40 MG | TABLET | APOTEX INC | MARKETED | DIN 02246057 |
| AURO-CITALOPRAM | 20 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02275562 |
Who else supplies CITALOPRAM worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CITALOPRAM appears in 433 registered pack listings across 15 markets, published on 13 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.